Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Besremi (ropeginterferon alfa-2B) to Treat Polycythaemia Vera

Ropeginterferon alfa-2B has been developed using PharmaEssentia’s novel pegylation technology platform. Image courtesy of Nevit Dilmen.



  • Besremi®
  • Besremi®
  • Besremi®

Go Top